Bills · HR 7091
IN COMMITTEE· 119TH CONGRESS
House BillHR 7091Armed Forces and National Security
Expanding Veterans’ Access to Emerging Treatments Act
INTRO JAN 15· LAST ACTION FEB 2
READING
4MIN
COSPONSORS
3BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it addresses a critical need for new solutions for veterans facing difficult and often debilitating health conditions where current treatments fall short. If it becomes law, it means the VA will actively explore and offer cutting-edge, even experimental, therapies for conditions like chronic pain and PTSD, including those that might involve psychedelics, potentially offering hope and new options where none existed before.
If it doesn't pass, veterans might continue to wait longer for access to these potentially life-changing treatments, relying solely on existing, sometimes less effective, options. This bill could accelerate the development and availability of new care pathways, directly improving the quality of life for many veterans.
KEY PROVISIONS
5AI-extractedPROVISION 01
Directs the VA to establish an investigational research and extended access program for innovative treatments within 90 days of the bill becoming law.
This creates a structured and timely pathway for veterans to access experimental therapies for conditions with unmet needs.
PROVISION 02
Allows the program to include specific innovative treatments like MDMA, psilocybin, and ketamine, as well as new medical devices and investigational drugs.
This specifically opens the door for research and access to a range of therapies that are currently highly restricted or not widely available.
PROVISION 03
Requires the VA to create a process for veterans diagnosed with a covered condition to participate in clinical trials or receive compassionate/extended access to these treatments.
This ensures veterans have a clear path to potentially benefiting from the program and receiving personalized care.
PROVISION 04
Requires the VA to submit a report to Congress within one year on the program's outcomes, findings, and a review of all utilized therapies, including safety and efficacy.
This provides transparency and oversight on the effectiveness and implementation of the program, ensuring accountability.
PROVISION 05
Defines specific 'covered conditions' such as chronic pain, PTSD, depression, and substance use disorders that the program will address, while also allowing the Secretary to designate other conditions.
This clearly identifies the target health issues for the program, providing both focus and flexibility.
SPONSORSHIP
1 + 3
R· Michigan
YRS IN OFFICE
9
BILLS LED
28
COSPONSOR BREAKDOWNBIPARTISAN · 66%
DEM 1 REP 2 IND 0
ACTION TIMELINE
3 EVENTSFEB 2
Referred to the Subcommittee on Health.
JAN 15
Introduced in House
JAN 15
Referred to the House Committee on Veterans' Affairs.
BILL INFO
TypeHouse Bill
NumberHR 7091
Congress119th
StatusIn Committee
IntroducedJan 15, 2026
Last actionFeb 2, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · VETERANS' AFFAIRS COMMITTEE · INTRODUCED JAN 15, 2026
House BillHR 7091Armed Forces and National Security
Expanding Veterans’ Access to Emerging Treatments Act
INTRODUCED JAN 15, 2026· LAST ACTION FEB 2, 2026
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
3
COMPLEXITY
Moderate
